US spending bill gives CDRH (Center for Devices and Radiological Health) $10.5 million increase in funds
This article was originally published in Clinica
Executive Summary
The FDA portion of the agriculture bill includes a $10.5 million increase in funding for the Center for Devices and Radiological Health (CDRH). The Senate is expected to quickly approve the bill, which also includes the lifting of sanctions on sales to Cuba, Iran, Libya, North Korea and Sudan.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.